A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
Some of the biggest packaged food companies raised their prices last quarter and their profits rose, but some customers were starting to cut back or trade down.
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.